This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Christoph Funk - Innovator in NK-1 Receptor Antagonists
Introduction
Christoph Funk is a notable inventor based in Bottmingen, Switzerland. He has made significant contributions to the field of pharmacology, particularly through his work on NK-1 receptor antagonists. His innovative approach has led to the development of compounds that hold promise for various therapeutic applications.
Latest Patents
Christoph Funk holds 1 patent related to NK-1 receptor antagonists. This patent encompasses compounds of formula I, which are designed to interact with the NK-1 receptor, potentially offering new avenues for treatment in related medical conditions.
Career Highlights
Funk is associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work at this esteemed organization has allowed him to focus on groundbreaking research and development in the pharmaceutical sector.
Collaborations
Throughout his career, Christoph Funk has collaborated with talented individuals such as Torsten Hoffmann and Andreas Koblet. These partnerships have fostered a creative environment that encourages innovation and the advancement of scientific knowledge.
Conclusion
Christoph Funk's contributions to the field of NK-1 receptor antagonists exemplify the impact of dedicated inventors in the pharmaceutical industry. His work continues to inspire future innovations in medicine.